| Notes |
Jonathan Engler 🇬🇧
DOCTOR AND MEDICAL INVESTOR
Jonathan started his career in clinical medicine. After a few years, he moved into the Pharma Industry, designing and running an international clinical trial program, before he and a colleague spotted a gap in the market for a company utilising IT to automate several clinical trial processes. The company they founded was sold, it had 6 offices worldwide and 500 employees. Jonathan then retrained as a lawyer, but having missed the commercial world he invested in several Healthcare start-ups, one of which (involved in cancer diagnostics) he now chairs.
Jonathan joined PANDA in response to disturbing international developments in 2020. He considers the need to promote honest science, open borders and personal autonomy to be vital to the future of humanity. |